Cleveland Clinic Rheumatology
Avatar

Inflammatory Arthritis and Sicca Syndrome Induced by Nivolumab and Ipilimumab

By Cleveland Clinic Rheumatology FEATURING Leonard Calabrese, Laura Cappelli, Cassandra Calabrese
By Cleveland Clinic Rheumatology FEATURING Leonard Calabrese, Laura Cappelli, Cassandra Calabrese
0 views
January 15, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

03:44
UCB Rheumatology

A Deeper Understanding of the Pathogenesis of axSpA

Feat. I. Mcinnes

Featured Video

02:48
UCB Rheumatology

A Deeper Understanding of the Pathogenesis of PsA

Feat. I. Mcinnes

Recommended

AUTOPLAY
08:49
David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
35:40
Balazs Halmos

Year in Review: Lung Cancer

17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
14:49
Vivek Subbiah

Year in Review: Precision Medicine

13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
19:33
ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

Feat. E. Felip, A. Spira, A. Passaro, A. Addeo
09:40
John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

16:12
Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon
09:37
Luis Raez

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

07:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…

Feat. J. West
28:21
Houston Methodist Hospital

Palliative Medicine in Cancer Patients

Feat. E. De Leon
20:27
Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
18:09
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

The Changing Prognosis of Lung Cancer Brain Metastases

Feat. S. Goldberg